Notice of Intent To Award Affordable Care Act Funding, Funding Opportunity Announcement CDC-RFA-DP09-905, 54774-54775 [2011-22499]
Download as PDF
<![CDATA[
54774
Federal Register / Vol. 76, No. 171 / Friday, September 2, 2011 / Notices
Therefore, the REACH program
activities CDC proposes to fund with
PPACA appropriations are authorized
by the amendment to the Public Health
Services Act which authorized the
Prevention and Wellness Program as
embodied in CDC–RFA–DP07–707.
Dated: August 22, 2011.
Tanja Popovic,
Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2011–22524 Filed 9–1–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Intent To Award Affordable
Care Act Funding, Funding
Opportunity Announcement CDC–
RFA–DP10–1014
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
This notice provides notice of
CDC’s intent to fund continuation
cooperative agreement applications
under REACH CORE, Racial and Ethnic
Approaches to Community Health
Communities Organized to Respond and
Evaluate. These applications have been
previously received and competed in
response to CDC Funding Opportunity
CDC–RFA–DP10–1014. It is the intent of
CDC to provide continuation funding to
one (1) previously received and
reviewed application with Patient
Protection Affordable Care Act
(PPACA), Section 4002, appropriations.
SUMMARY:
erowe on DSK5CLS3C1PROD with NOTICES
Recipient Reporting Requirements
Under PPACA
Recipients funded with PPACA
appropriations will be required to report
project status on an annual basis.
Specific reporting requirements will be
detailed in the Terms and Conditions of
the Notice of Cooperative Agreement
Award.
CFDA Number 93.541 is the PPACA
specific CFDA number for this
initiative. It will replace CFDA Number
93.283 published in the above
referenced REACH CORE Funding
Opportunity Announcement (FOA).
Award Information
Approximate Current Fiscal Year
Funding: $199,700.
Approximate Number of Awards: 1.
Approximate Average Awards:
$199,700.
VerDate Mar<15>2010
15:37 Sep 01, 2011
Jkt 223001
Fiscal Year Funds: 2011.
Anticipated Award Date: September
30, 2011.
Budget Period: 12 months.
Project Period: 12 months.
Application Selection Process:
Grantees have been selected based on
methodology published in the REACH
CORE CDC–RFA–DP10–1014 FOA.
Applications were funded in order by
score and rank determined by
previously held review panel. In
addition, as was referenced in the
REACH CORE FOA, funding decisions
were made to ensure:
• Geographic diversity across the
United States.
• Inclusion of each racial/ethnic
group that is specified in CDC–RFA–
DP10–1014 is represented.
• Inclusions of each health priority
areas that are specified in CDC–RFA–
DP10–1014 are represented.
• Representation of communities
with evident health disparities.
• Communities who currently lack
access to health priority area-related
resources and/or with high levels of
poverty are represented as documented
in the application.
CDC will add the following Authority to
that which is reflected in the published
Funding Opportunity: Section 4002 of
the Patient Protection and Affordability
Care Act (Pub. L. 111–148).
DATES: The effective date for this action
is September 2, 2011 and remains in
effect until the expiration of the one (1)
year project period of the PPACA
funded applications.
FOR FURTHER INFORMATION CONTACT:
Elmira Benson, Deputy Director,
Procurement and Grants Office, Centers
for Disease Control and Prevention,
2920 Brandywine Road, Atlanta, GA
30341, telephone: (770)488–2802, email: EBenson@cdc.gov.
SUPPLEMENTARY INFORMATION: On March
23, 2010, the President signed into law
the Patient Protection and Affordable
Care Act (PPACA). PPACA is designed
to improve and expand the scope of
health care coverage for Americans. Cost
savings through disease prevention is an
important element of this legislation
and PPACA has established a
Prevention and Public Health Fund
(PPHF) for this purpose. Specifically,
the legislation states in Section 4002
that the PPHF is to ‘‘provide for
expanded and sustained national
investment in prevention and public
health programs to improve health and
help restrain the rate of growth in
private and public sector health care
costs’’. PPACA and the Prevention and
Public Health Fund make improving
public health a priority with
investments to improve public health.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
The PPHF states that the Secretary
shall transfer amounts in the Fund to
accounts within the Department of
Health and Human Services to increase
funding, over the fiscal year 2008 level,
for programs authorized by the public
Health Services Act, for prevention,
wellness and public health activities
including prevention research and
health screenings, such as the
Community Transformation Grant
Program, the Education and Outreach
Campaign for Preventative Benefits, and
Immunization Programs.
REACH CORE and PPACA legislation
affords an important opportunity to
advance public health across the
lifespan and to reduce health disparities
by supporting an intensive community
approach to chronic disease prevention
and control. Therefore, awarding
cooperative agreements with PPACA
funds under PPHF to existing grantees
to carry out REACH objectives is
consistent with the purpose of PPHF, as
stated above, to provide for the
expanded and sustained national
investment in prevention and public
health programs. Further, the Secretary
allocated funds to CDC, pursuant to the
PPHF, for the types of activities that the
REACH initiatives are designed to carry
out.
Therefore, the REACH program
activities CDC proposes to fund with
PPACA appropriations are authorized
by the amendment to the Public Health
Services Act which authorized the
Prevention and Wellness Program as
embodied in CDC–RFA–DP10–1014.
Dated: August 22, 2011.
Tanja Popovic,
Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2011–22528 Filed 9–1–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Intent To Award Affordable
Care Act Funding, Funding
Opportunity Announcement CDC–
RFA–DP09–905
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
This notice provides notice of
CDC’s intent to fund continuation
cooperative agreement applications
under the Racial and Ethnic Approaches
to Community Health National
SUMMARY:
E:\FR\FM\02SEN1.SGM
02SEN1
Federal Register / Vol. 76, No. 171 / Friday, September 2, 2011 / Notices
Organizations that Serve Minority
Communities, REACH MNO. These
applications have been previously
received and competed in response to
CDC Funding Opportunity CDC–RFA–
DP09–905. It is the intent of CDC to
provide continuation funding to three
(3) previously received and reviewed
applications with Patient Protection
Affordable Care Act (PPACA), Section
4002, appropriations.
Recipient Reporting Requirements
Under PPACA
Recipients funded with PPACA
appropriations will be required to report
project status on an annual basis.
Specific reporting requirements will be
detailed in the Terms and Conditions of
the Notice of Cooperative Agreement
Award.
CFDA Number 93.541 is the PPACA
specific CFDA number for this
initiative. It will replace CFDA Number
93.283 published in the above
referenced REACH MNO Funding
Opportunity Announcement (FOA).
erowe on DSK5CLS3C1PROD with NOTICES
Award Information
Approximate Current Fiscal Year
Funding: $750,000.
Approximate Number of Awards: 3.
Approximate Average Awards:
$250,000.
Fiscal Year Funds: 2011.
Anticipated Award Date: September
30, 2011.
Budget Period: 12 months.
Project Period: 12 months.
Application Selection Process:
Grantees have been selected based on
methodology published in the REACH
MNO CDC–RFA–DP09–905 FOA.
Applications were funded in order by
score and rank determined by
previously held review panel.
CDC will add the following Authority
to that which is reflected in the
published Funding Opportunity:
Section 4002 of the Patient Protection
and Affordability Care Act (Pub. L. 111–
148).
DATES: The effective date for this action
is September 2, 2011 and remains in
effect until the expiration of the one (1)
year project period of the PPACA
funded applications.
FOR FURTHER INFORMATION CONTACT:
Elmira Benson, Deputy Director,
Procurement and Grants Office, Centers
for Disease Control and Prevention,
2920 Brandywine Road, Atlanta, GA
30341, telephone: (770) 488–2802,
e-mail: EBenson@cdc.gov.
SUPPLEMENTARY INFORMATION: On March
23, 2010, the President signed into law
the Patient Protection and Affordable
Care Act (PPACA). PPACA is designed
VerDate Mar<15>2010
15:37 Sep 01, 2011
Jkt 223001
to improve and expand the scope of
health care coverage for Americans. Cost
savings through disease prevention is an
important element of this legislation
and PPACA has established a
Prevention and Public Health Fund
(PPHF) for this purpose. Specifically,
the legislation states in Section 4002
that the PPHF is to ‘‘provide for
expanded and sustained national
investment in prevention and public
health programs to improve health and
help restrain the rate of growth in
private and public sector health care
costs’’. PPACA and the Prevention and
Public Health Fund make improving
public health a priority with
investments to improve public health.
The PPHF states that the Secretary
shall transfer amounts in the Fund to
accounts within the Department of
Health and Human Services to increase
funding, over the fiscal year 2008 level,
for programs authorized by the public
Health Services Act, for prevention,
wellness and public health activities
including prevention research and
health screenings, such as the
Community Transformation Grant
Program, the Education and Outreach
Campaign for Preventative Benefits, and
Immunization Programs.
REACH MNO and PPACA legislation
affords an important opportunity to
advance public health across the
lifespan and to reduce health disparities
by supporting an intensive community
approach to chronic disease prevention
and control. Therefore, awarding
cooperative agreements with PPACA
funds under PPHF to existing grantees
to carry out REACH objectives is
consistent with the purpose of PPHF, as
stated above, to provide for the
expanded and sustained national
investment in prevention and public
health programs. Further, the Secretary
allocated funds to CDC, pursuant to the
PPHF, for the types of activities that the
REACH initiatives are designed to carry
out.
Therefore, the REACH program
activities CDC proposes to fund with
PPACA appropriations are authorized
by the amendment to the Public Health
Services Act which authorized the
Prevention and Wellness Program as
embodied in CDC–RFA–DP09–905.
Dated: August 22, 2011.
Tanja Popovic,
Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2011–22499 Filed 9–1–11; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
54775
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee on Procedures Review,
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 9 a.m.–5 p.m.,
September 19, 2011.
Place: Cincinnati Airport Marriott,
2395 Progress Drive, Hebron, Kentucky
41018, Telephone: (859) 334–4611, Fax:
(859) 334–4619.
Status: Open to the public. In the
event an individual wishes to provide
comments, written comments must be
submitted prior to the meeting. To
access by conference call dial the
following information: (866) 659–0537,
Participant Pass Code 9933701.
Background: The ABRWH was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
compensation program. Key functions of
the ABRWH include providing advice
on the development of probability of
causation guidelines that have been
promulgated by the Department of
Health and Human Services (HHS) as a
final rule; advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule;
advice on the scientific validity and
quality of dose estimation and
reconstruction efforts being performed
for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special
Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the ABRWH to
HHS, which subsequently delegated this
authority to CDC. NIOSH implements
this responsibility for CDC. The charter
was issued on August 3, 2001, renewed
at appropriate intervals, and will expire
on August 3, 2013.
Purpose: The ABRWH is charged with
(a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b)
providing advice to the Secretary, HHS,
on the scientific validity and quality of
E:\FR\FM\02SEN1.SGM
02SEN1
]]>Agencies
[Federal Register Volume 76, Number 171 (Friday, September 2, 2011)]
[Notices]
[Pages 54774-54775]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-22499]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Intent To Award Affordable Care Act Funding, Funding
Opportunity Announcement CDC-RFA-DP09-905
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice provides notice of CDC's intent to fund
continuation cooperative agreement applications under the Racial and
Ethnic Approaches to Community Health National
[[Page 54775]]
Organizations that Serve Minority Communities, REACH MNO. These
applications have been previously received and competed in response to
CDC Funding Opportunity CDC-RFA-DP09-905. It is the intent of CDC to
provide continuation funding to three (3) previously received and
reviewed applications with Patient Protection Affordable Care Act
(PPACA), Section 4002, appropriations.
Recipient Reporting Requirements Under PPACA
Recipients funded with PPACA appropriations will be required to
report project status on an annual basis. Specific reporting
requirements will be detailed in the Terms and Conditions of the Notice
of Cooperative Agreement Award.
CFDA Number 93.541 is the PPACA specific CFDA number for this
initiative. It will replace CFDA Number 93.283 published in the above
referenced REACH MNO Funding Opportunity Announcement (FOA).
Award Information
Approximate Current Fiscal Year Funding: $750,000.
Approximate Number of Awards: 3.
Approximate Average Awards: $250,000.
Fiscal Year Funds: 2011.
Anticipated Award Date: September 30, 2011.
Budget Period: 12 months.
Project Period: 12 months.
Application Selection Process: Grantees have been selected based on
methodology published in the REACH MNO CDC-RFA-DP09-905 FOA.
Applications were funded in order by score and rank determined by
previously held review panel.
CDC will add the following Authority to that which is reflected in
the published Funding Opportunity: Section 4002 of the Patient
Protection and Affordability Care Act (Pub. L. 111-148).
DATES: The effective date for this action is September 2, 2011 and
remains in effect until the expiration of the one (1) year project
period of the PPACA funded applications.
FOR FURTHER INFORMATION CONTACT: Elmira Benson, Deputy Director,
Procurement and Grants Office, Centers for Disease Control and
Prevention, 2920 Brandywine Road, Atlanta, GA 30341, telephone: (770)
488-2802, e-mail: EBenson@cdc.gov.
SUPPLEMENTARY INFORMATION: On March 23, 2010, the President signed into
law the Patient Protection and Affordable Care Act (PPACA). PPACA is
designed to improve and expand the scope of health care coverage for
Americans. Cost savings through disease prevention is an important
element of this legislation and PPACA has established a Prevention and
Public Health Fund (PPHF) for this purpose. Specifically, the
legislation states in Section 4002 that the PPHF is to ``provide for
expanded and sustained national investment in prevention and public
health programs to improve health and help restrain the rate of growth
in private and public sector health care costs''. PPACA and the
Prevention and Public Health Fund make improving public health a
priority with investments to improve public health.
The PPHF states that the Secretary shall transfer amounts in the
Fund to accounts within the Department of Health and Human Services to
increase funding, over the fiscal year 2008 level, for programs
authorized by the public Health Services Act, for prevention, wellness
and public health activities including prevention research and health
screenings, such as the Community Transformation Grant Program, the
Education and Outreach Campaign for Preventative Benefits, and
Immunization Programs.
REACH MNO and PPACA legislation affords an important opportunity to
advance public health across the lifespan and to reduce health
disparities by supporting an intensive community approach to chronic
disease prevention and control. Therefore, awarding cooperative
agreements with PPACA funds under PPHF to existing grantees to carry
out REACH objectives is consistent with the purpose of PPHF, as stated
above, to provide for the expanded and sustained national investment in
prevention and public health programs. Further, the Secretary allocated
funds to CDC, pursuant to the PPHF, for the types of activities that
the REACH initiatives are designed to carry out.
Therefore, the REACH program activities CDC proposes to fund with
PPACA appropriations are authorized by the amendment to the Public
Health Services Act which authorized the Prevention and Wellness
Program as embodied in CDC-RFA-DP09-905.
Dated: August 22, 2011.
Tanja Popovic,
Deputy Associate Director for Science, Centers for Disease Control and
Prevention.
[FR Doc. 2011-22499 Filed 9-1-11; 8:45 am]
BILLING CODE 4163-18-P
